Zomig, Zomig Rapimelt (zolmitriptan)

Zomig (zolmitriptan) is a a selective 5-hydroxytryptamine 1B/1D (5-HT 1B/1D ) receptor agonist or 'triptan' for acute treatment of migraine attacks with or without aura, and is available in oral and nasal spray forms.

SPC/PILFor Summary of Product Characteristics and Patient Information Leaflet click this link

 

 

Approval ID: 155,827.011
Date of preparation: June 2014